Researchers unlock cancer cells' feeding mechanism, central to tumor growth

by University of CincinnatiAtsuo Sasaki, Ph.D., associate professor at the UC College of Medicine Credit: Colleen Kelley / UC Creative ServicesAn international team led by researchers from the Un

Updated on: June 11,2024

Researchers unlock cancer cells' feeding mechanism, central to tumor growth

by University of CincinnatiAtsuo Sasaki, Ph.D., associate professor at the UC College of Medicine Credit: Colleen Kelley / UC Creative ServicesAn international team led by researchers from the Un

Updated on:June 11,2024

A predictive biomarker of response to therapy in patients with microsatellite stable metastatic colorectal cancer

by Vall d'Hebron Institute of OncologyA total of 166 patients with mCRCBRAF-V600Ewere included in the study from discovery (n = 46), validation (n = 52) and control (n = 68) cohorts. WES of

Updated on: January 08,2024

A predictive biomarker of response to therapy in patients with microsatellite stable metastatic colorectal cancer

by Vall d'Hebron Institute of OncologyA total of 166 patients with mCRCBRAF-V600Ewere included in the study from discovery (n = 46), validation (n = 52) and control (n = 68) cohorts. WES of

Updated on:January 08,2024

Most Americans don't know about lung cancer screening, survey shows

by Ernie MundellCredit: Anna Tarazevich from PexelsPeople who've had a history of smoking can get alung cancerspotted early—when it's most treatable—through annual CT screening.Unf

Updated on: August 27,2024

Most Americans don't know about lung cancer screening, survey shows

by Ernie MundellCredit: Anna Tarazevich from PexelsPeople who've had a history of smoking can get alung cancerspotted early—when it's most treatable—through annual CT screening.Unf

Updated on:August 27,2024

As cancer treatment advances, patients and doctors push back against drugs' harsh side effects

by Carla K. JohnsonJill Feldman, 54, poses for a photo at her home in Deerfield, Ill., Friday, Jan. 19, 2024. Lung cancer patient and advocate Jill Feldman takes pills at home that shrink tumors by bl

Updated on: June 25,2024

As cancer treatment advances, patients and doctors push back against drugs' harsh side effects

by Carla K. JohnsonJill Feldman, 54, poses for a photo at her home in Deerfield, Ill., Friday, Jan. 19, 2024. Lung cancer patient and advocate Jill Feldman takes pills at home that shrink tumors by bl

Updated on:June 25,2024

Prostate cancer: Family history, genetics and your risk

by Jessica Saenz,Mayo ClinicCredit: Kampus Production from PexelsIf you've been diagnosed with prostate cancer, exploring what may have contributed to your cancer might not be at the top of

Updated on: November 10,2024

Prostate cancer: Family history, genetics and your risk

by Jessica Saenz,Mayo ClinicCredit: Kampus Production from PexelsIf you've been diagnosed with prostate cancer, exploring what may have contributed to your cancer might not be at the top of

Updated on:November 10,2024

How a little-known glycoprotein blocks a cancer cell's immune response

by University of MichiganThe interaction between STC1 and calreticulin. Credit: University of Michigan Rogel Cancer CenterIt was an unexpected discovery that started with an analysis of more than

Updated on: March 26,2024

How a little-known glycoprotein blocks a cancer cell's immune response

by University of MichiganThe interaction between STC1 and calreticulin. Credit: University of Michigan Rogel Cancer CenterIt was an unexpected discovery that started with an analysis of more than

Updated on:March 26,2024

Researchers study the risk of false positives in colon cancer screening

by IDIBELL-Bellvitge Biomedical Research InstituteCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Colorectal cancer can develop for months without producing any s

Updated on: June 04,2024

Researchers study the risk of false positives in colon cancer screening

by IDIBELL-Bellvitge Biomedical Research InstituteCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Colorectal cancer can develop for months without producing any s

Updated on:June 04,2024

Advancing cervical cancer prevention in China: New insights and future strategies

byChinese Academy of SciencesNumber of areas providing free or subsidized HPV vaccination. Credit:Cancer Biology & Medicine(2024). DOI: 10.20892/j.issn.2095-3941.2023.0432As the

Updated on: July 06,2024

Advancing cervical cancer prevention in China: New insights and future strategies

byChinese Academy of SciencesNumber of areas providing free or subsidized HPV vaccination. Credit:Cancer Biology & Medicine(2024). DOI: 10.20892/j.issn.2095-3941.2023.0432As the

Updated on:July 06,2024

Research details adaptation tactics of pancreatic cancer

byUniversity of OklahomaPSCs support cancer cell growth by the secretion of acetate under acidosis. Credit:Nature Cell Biology(2024). DOI: 10.1038/s41556-024-01372-4Like alien invade

Updated on: April 28,2024

Research details adaptation tactics of pancreatic cancer

byUniversity of OklahomaPSCs support cancer cell growth by the secretion of acetate under acidosis. Credit:Nature Cell Biology(2024). DOI: 10.1038/s41556-024-01372-4Like alien invade

Updated on:April 28,2024

Significant proportion of cancer drugs lack proof of added benefit, finds study

by British Medical JournalCredit: CC0 Public DomainMany cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved

Updated on: May 26,2024

Significant proportion of cancer drugs lack proof of added benefit, finds study

by British Medical JournalCredit: CC0 Public DomainMany cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved

Updated on:May 26,2024

Adjuvant nivolumab + ipilimumab lacks efficacy for localized renal cell carcinoma

Disease-free survival (DFS) does not differ with adjuvant nivolumab plus ipilimumab (NIVO+IPI) compared with placebo in patients with localized renal cell carcinoma (RCC) at high risk for postnephrect

Updated on: December 22,2023

Adjuvant nivolumab + ipilimumab lacks efficacy for localized renal cell carcinoma

Disease-free survival (DFS) does not differ with adjuvant nivolumab plus ipilimumab (NIVO+IPI) compared with placebo in patients with localized renal cell carcinoma (RCC) at high risk for postnephrect

Updated on:December 22,2023

Study reveals significant global disparities in cancer care across different countries

byWileyCredit: Pixabay/CC0 Public DomainA recent analysis reveals striking disparities in the cost and availability of cancer drugs across different regions of the globe, with significant gaps b

Updated on: November 30,2024

Study reveals significant global disparities in cancer care across different countries

byWileyCredit: Pixabay/CC0 Public DomainA recent analysis reveals striking disparities in the cost and availability of cancer drugs across different regions of the globe, with significant gaps b

Updated on:November 30,2024